infection/Infestation
Conditions
Interventions
X worm mebendazole
Vermox Mebendazole
Sponsors
Uiversity of Gonder
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Study participants whose age ranges from 6-14 years Individuals confirmed with Ascaris lumbricoides and hookworm mono-infection
Exclusion criteria
Exclusion criteria: Presence or history of known major systemic or chronic illnesses (based on physical examination and Medical history and student interview) Received anthelminthic treatment or metronidazole within the past four weeks. Attending other clinical trials during the study periods. Experienced a severe allergic reaction to mebendazole(interviewing study participants), Infected with other parasitic infections Diarrheic children Children vomited within 4 hours after the drug taken Unable to give sufficient sample
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cure rate or CR. CR means the proportion of individual hosts positive for parasites who become parasitologically negative after treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| Arithmetic mean of Feacal Egg Reduction Rate OR ERR. ERR is the arithmetic mean egg count at baseline of the treatment group minus mean egg count at the end of treatment period divided by the mean egg count at the baseline and express it in percent. | — |
Countries
Ethiopia
Contacts
Public ContactAyalew Jejaw
Lecturer
Outcome results
None listed